About Vanan Pharma
Vanan Pharma is a Healthcare company based in Piscataway (United States) founded in 2010. It develops patented creams for skin infections, burns, and dermatitis treatments globally. It operates on a B2B model. The company has 1 employees. Its Indian entity Vanan Pharma Private Limited reported revenue of ₹1.31 Cr. Vanan Pharma offers products and services including Sodium Fusidate Cream, Silver Sulfadiazine Cream, and Betamethasone Valerate & Neomycin Sulfate Cream. Its focus areas include Healthcare and Life Sciences, Pharmaceuticals, R&D Services and Formulation Development.
Company details
Vanan Pharma creates patented formulations for skin care, focusing on bacterial infections, burn wounds, and dermatitis. They operate through RD, manufacturing, and marketing sectors, supported by an exclusive facility. Based in New York, they deliver quality products worldwide using innovative biopolymer technology, targeting healthcare needs without promotional emphasis.
- Headquarters Piscataway, United States
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vananpharma.com
- Legal Name Vanan Pharma Private Limited
- Date of Incorporation 20 Nov, 2002
- Jurisdiction Chennai, Tamil Nadu, India
- Indian entity revenue₹1.31 Cr
FY 2025 · -45% YoY
- Indian entity net profit₹62.1 Lakh
FY 2025 · 47% margin
- Indian entity EBITDA₹78.4 Lakh
FY 2025 · 60% margin
- Employee Count1
Associated legal entities of Vanan Pharma
Vanan Pharma operates through Vanan Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vanan Pharma Private Limited CIN U24231TN2002PTC049892 | Active | 20 Nov 2002 | Chennai, Tamil Nadu | ₹1.3 Cr | 5 | View details |
Products & Services of Vanan Pharma
Vanan Pharma offers a comprehensive portfolio of products and services, including Sodium Fusidate Cream, Silver Sulfadiazine Cream, and Betamethasone Valerate & Neomycin Sulfate Cream.
Cream for treating bacterial skin infections using patented biopolymer.
Cream for burn wounds with silver sulfadiazine and biopolymer technology.
Cream for dermatitis and secondary infections with chitosan biopolymer.
Board of directors of Vanan Pharma Private Limited (Vanan Pharma)
Vanan Pharma Private Limited is the primary company behind Vanan Pharma. The board of Vanan Pharma Private Limited currently have 4 directors; the longest-serving is Sulur Vanangamudi Subramaniam, appointed in 2010. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sulur Vanangamudi Subramaniam DIN 00056717 | Director | 15 Sep 2010 | 16 yrs 1 mo | Vanan Pharma Private Limited |
| Vishagan DIN 06442153 | Director | 01 Oct 2021 | 5 yrs | Vanan Pharma Private Limited |
| Srinivasan Murali DIN 01812061 | Director | 01 Sep 2022 | 4 yrs 1 mo | Vanan Pharma Private Limited |
| Usha Vanangamudi DIN 02490999 | Director | 01 Apr 2023 | 3 yrs 6 mo | Vanan Pharma Private Limited |
People of Vanan Pharma
21 people are tracked at Vanan Pharma (8 in leadership, 13 in team); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Dr.l. Ramanathan | Associate Vice President | Leadership |
Karthikeyan T | Associate Vice President- Sales & Marketing | Leadership |
Subashini Vanangamudi | Chairman & Managing Director | Leadership |
Satheesh Kumar | General Manager Marketing | Leadership |
Meganathan Mohan | Sr.vice President - Sales & Marketing | Leadership |
S.abdul Sukkur | Vice President,sales & Marketing | Leadership |
Harihara Subramanian | Head R&d | Leadership |
Sridhar Ramasubramanian | Vice President Sales Marketing | Leadership |
Manoj Kumar | Quality Assurance Executive | Team |
Sashi S | RSM | Team |
Raaj Dhinakaran | Marketing Manager | Team |
Karthick S | Quality Control Analyst | Team |
Ramesh Mall | Marketing | Team |
Prakash Thiagarajan | Executive Accounts | Team |
Saurabh Yadav | Sales And Marketing Specialist | Team |
Murli Manohar Chaudhary | Regional Sales Manager | Team |
Subramaniam Lakshminarayanan | Deputy Manager | Team |
Malathy Balakumar | Executive | Team |
Gayathri Mano | Senior Executive | Team |
Sivakumar B | Senior Marketing Manager | Team |
1 more people are available in the full profile.
Complete people profiles for Vanan Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Vanan Pharma
Figures of Vanan Pharma Private Limited, the primary company behind Vanan Pharma, for FY 2025. Revenue was ₹1.31 Cr (-45% year on year). Net profit was ₹62.1 Lakh (47% margin). EBITDA was ₹78.4 Lakh (60% margin). Revenue has grown at a compounded annual rate of +34% over three years and +20% over five years.
- ₹1.31 CrRevenue · FY 2025 · -45% YoY
- ₹62.1 LakhNet profit · 47% margin
- ₹78.4 LakhEBITDA · 60% margin
- ₹25.95 CrPaid-up capital
- +34%Revenue CAGR, 3 years
- +20%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vanan Pharma Private Limited are on its company page.
Detailed financial statements for Vanan Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Vanan Pharma (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 61.16 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vanan Pharma
Vanan Pharma was founded in 2010.
Vanan Pharma is headquartered in Piscataway, United States. It is registered at Piscataway, New Jersey, United States.
Vanan Pharma has 1 employees.
The primary company behind Vanan Pharma, Vanan Pharma Private Limited, reported revenue of ₹1.31 Cr for FY 2025, down 45% year on year.
Vanan Pharma creates patented formulations for skin care, focusing on bacterial infections, burn wounds, and dermatitis. They operate through RD, manufacturing, and marketing sectors, supported by an exclusive facility. Based in New York, they deliver quality products worldwide using innovative biopolymer technology, targeting healthcare needs without promotional emphasis.
Vanan Pharma offers Sodium Fusidate Cream, Silver Sulfadiazine Cream, and Betamethasone Valerate & Neomycin Sulfate Cream.
Vanan Pharma operates through Vanan Pharma Private Limited.
The legal entities of Vanan Pharma currently have 5 directors, including Srinivasan Murali, Harshini, Sulur Vanangamudi Subramaniam and others.